{"cluster": 63, "subcluster": 11, "abstract_summ": "RECENT FINDINGS: At present, the strategy of new use of old drugs is mainly used to screen candidate drugs against the novel coronavirus (later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) and inhibit excessive immune response.The outbreak of the COVID-19 pandemic has spurred an intense global effort to repurpose existing approved drugs for its treatment.In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.The COVID-19 pandemic has highlighted an important role for drug repurposing.However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery.Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent.", "title_summ": "Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for SupplyProbable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know MoreCOVID-19 Drug Treatment in ChinaPlausible mechanisms of Niclosamide as an antiviral agent against COVID-19Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic PotentialRepurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19Doxycycline as a potential partner of COVID-19 therapiesA proposed mechanism for the possible therapeutic potential of Metformin in COVID-19Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs:", "title_abstract_phrases": "In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19The COVID-19 pandemic has highlighted an important role for drug repurposing.The outbreak of the COVID-19 pandemic has spurred an intense global effort to repurpose existing approved drugs for its treatment.Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply[Image: see text]USFDA approve this drug for the treatment of COVID-19.However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery."}